UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 9,100 Shares of Humana Inc. (NYSE:HUM)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Humana Inc. (NYSE:HUM) by 1.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 856,954 shares of the insurance provider’s stock after purchasing an additional 9,100 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.71% of Humana worth $271,432,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV boosted its stake in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after buying an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. increased its position in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Atwood & Palmer Inc. bought a new stake in Humana in the third quarter worth $29,000. Ashton Thomas Securities LLC bought a new stake in Humana in the third quarter worth $31,000. Finally, Your Advocates Ltd. LLP boosted its stake in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on HUM shares. JPMorgan Chase & Co. raised their target price on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. UBS Group cut their target price on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Barclays raised their price target on Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. TD Cowen increased their target price on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Finally, Wells Fargo & Company lowered their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Stock Up 0.0 %

Shares of HUM opened at $296.78 on Friday. The firm has a market cap of $35.74 billion, a P/E ratio of 26.29, a PEG ratio of 2.34 and a beta of 0.52. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $504.79. The stock’s 50 day moving average is $275.33 and its two-hundred day moving average is $329.47. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Analysts predict that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.19%. Humana’s dividend payout ratio is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.